Umang Swami
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Neeraj AgarwalSanjay GoelTaylor Ryan McFarlandRoberto NussenzveigMohammed MilhemYousef ZakhariaSridhar ManiNicolas Sayegh
- Topics
- Prostate Cancer Treatment and Research (78 papers)Cancer Immunotherapy and Biomarkers (39 papers)Radiopharmaceutical Chemistry and Applications (28 papers)
- Journals
- CirculationJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Umang Swami
147 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Oncology 727
- Pulmonary and Respiratory Medicine 634
- Molecular Biology 468
- Cancer Research 282
- Radiology, Nuclear Medicine and Imaging 179
Countries citing papers authored by Umang Swami
This map shows the geographic impact of Umang Swami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umang Swami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umang Swami more than expected).
Fields of papers citing papers by Umang Swami
This network shows the impact of papers produced by Umang Swami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umang Swami. The network helps show where Umang Swami may publish in the future.
Co-authorship network of co-authors of Umang Swami
This figure shows the co-authorship network connecting the top 25 collaborators of Umang Swami. A scholar is included among the top collaborators of Umang Swami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umang Swami. Umang Swami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 16 | |
| 12 | 1 | |
| 13 | 5 | |
| 14 | 6 | |
| 15 | 9 | |
| 16 | 5 | |
| 17 | 2 | |
| 18 | 2 | |
| 19 | 40 | |
| 20 | 11 |
About Umang Swami
Umang Swami is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 173 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (78 papers), Cancer Immunotherapy and Biomarkers (39 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). The work is most often cited by research in Health Informatics (51 citations), Oncology (727 citations) and Pulmonary and Respiratory Medicine (634 citations). Umang Swami has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Neeraj Agarwal, Sanjay Goel, Taylor Ryan McFarland, Roberto Nussenzveig, Mohammed Milhem, Yousef Zakharia, Sridhar Mani, Nicolas Sayegh, Benjamin L. Maughan and Nishita Tripathi. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.